[1]
“8-Propyl-6H-[1,3]dioxolo[4,5-g]chromen-6-one: A new coumarin with monoamine oxidase B inhibitory activity and possible anti-parkinsonian effects”, Braz. J. Pharm. Sci., vol. 56, p. e17609, Dec. 2020, doi: 10.1590/s2175-97902019000317609.